Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 12, 1999, Pages 707-711

  Soulie P ^a   Garrino, C ^a   Bensmaine M A ^a   Bekradda, M ^a   Brain, E ^a   Di Palma, M ^a   Goupil, A ^a   Misset, J L ^a   Cvitkovic, E ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

Germ cell tumors; Oxaliplatin; Salvage treatment

Indexed keywords

ALPHA FETOPROTEIN; BLEOMYCIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; DACTINOMYCIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; NAVELBINE; OXALIPLATIN; PLATINUM COMPLEX;

ADOLESCENT; ADULT; ARTICLE; ATAXIA; CLINICAL ARTICLE; CYTOTOXICITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SENSITIVITY; DRUG TOLERANCE; FEBRILE NEUTROPENIA; GERM CELL TUMOR; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CANCER; LUNG CANCER; PARESTHESIA; PRIORITY JOURNAL; SALVAGE THERAPY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALPHA-FETOPROTEINS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CISPLATIN; DACTINOMYCIN; DRUG RESISTANCE, NEOPLASM; DRUG THERAPY, COMBINATION; EPIRUBICIN; ETOPOSIDE; GERMINOMA; HUMANS; IFOSFAMIDE; MALE; NEOPLASM RECURRENCE, LOCAL; NEUTROPENIA; ORGANOPLATINUM COMPOUNDS; SALVAGE THERAPY; TESTICULAR NEOPLASMS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VINBLASTINE;

EID: 0032705990     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050338     Document Type: Article

References (22)

1. Beyer J, Kramar A, Mandanas R, Linkesch W, Greinix A, Droz JP, Pico JL, Diehl A, Bokemeyer C, Schmoll HJ, Nichols CR, Einhorn LH, Siegert W (1996) High-dose chemotherapy as salvage treatment in germ cell tumors A multivariate analysis of prognostic variable. J Clin Oncol 14:2638-2645
2. Bokemeyer C, Droz JP, Hanauske A, Schroder M, Queisser W, Schmoll HJ (1993) Treatment of relapsed non seminomatous germ cell tumors with vinorelbine: a trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society. Onkologie 16:29-31
3. Bokemeyer C, Beyer J, Metzner B, Rüther U, Harstrick A, Weibbach L, Köhrmann U, Verbeek W, Schmoll HJ (1996) Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. Ann Oncol 7:31-34
4. Culine S, Kramar A, Biron P, Droz JP (1996) Chemotherapy in adult germ cell tumors. Crit Rev Oncol Hemat 22:229-263
5. Dunn TA, Schmoll HJ, Grunwald V, Bokemeyer C, Casper J (1997) Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines. Invest New Drugs 15:109-114
6. Faivre S, Bourdon O, Bensmaine MA, Extra JM, Gautier H, Cvitkovic E, Marty M (1997) Paclitaxel (TXL)/oxaliplatin (L-OHP) association in pretreated recurrent ovarian carcinoma (ROC) patients. Proc Am Soc Clin Oncol 38:1315
7. Farhat F, Culine S, Theodore C, Bekradda M, Terrier-Lacombe MJ, Droz JP (1996) Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ celt tumor patients. Cancer 77:1193-1197
8. Ghosn M, Droz JP, Theodore C, Pico JL, Baume D, Spielmann M, Ostronoff M, Moran A, Salloum E, Kramar A, Hayat M (1988) Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. Cancer 62:24-27
9. Harstrick A, Schmoll HJ, Wilke H, Schöbr C, Stahl M, Köhne Wömpner C, Bokemeyer C, Dölken G, Burk K, Poliwada H (1990) High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II study. Ann Oncol 1:375-376
10. International Germ Cell Cancer Collaborative Group (1997) International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15:594-603
11. Loehrer PJ, Einhorn LH, Williams SD (1986) VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer. J Clin Oncol 4:528-536
12. Mathé G, Chenu E, Bourut C (1989) Experimental study of three platinum complexes: CDDP, CBDCA and 1-OHP on L1210 leukemia. Alternate of simultaneous association of two platinum complexes. Invest New Drugs 7:404
13. McCaffrey JA, Mazumdar M, Bajorin DJ, Bosl GJ, Vlamis V, Motzer RJ (1997) Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival. J Clin Oncol 15:2559-2563
14. Motzer RJ, Bosl GJ (1992) High-dose chemotherapy for resistant germ cell tumors: recent advances and future directions. J Natl Cancer Inst 84:1703-1709
15. Motzer RJ, Cooper K, Geller NL, Bajorin DF, Dmitrovsky E, Herr H, Morse M, Fair W, Sogani P, Russo P, Bosl GJ (1990) The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors. Cancer 66:2476-2481
16. Nichols CR, Roth BJ, Loehrer PJ, Williams SD, Einhorn LH (1994) Salvage chemotherapy for recurrent germ cell cancer. Semin Oncol 21:102-108
17. Ortuzar W, Paull K, Rixe O, Fojo T (1994) Comparison of the activity of cisplatin (CP) and oxaliplatin (OXALI) alone or in combination in parental and drug resistant sublines. Proc Am Assoc Cancer Res 35:332
18. Raymond E, Chaney S, Taamma A, Cvitkovic E (1998) Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol 9:1053-1071
19. Soulié P, Raymond E, Misset JL, Cvitkovic E (1996) Oxaliplatin: update on a active and safe DACH platinum complex. In: Pinedo HM, Schornagel JH (eds) Platinum and other metal coordination compounds in cancer chemotherapy, vol 2. Plenum, New York, p 165
20. Soulié P, Bensmaine A, Garrino C, Chollet P, Brain E, Fereres M, Jasmin C, Musset M, Misset JL and Cvitkovic E (1997) Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pre-treated ovarian cancer. Eur J Cancer 33:1400-1406
21. Weinstein JN, Myers TG, O' Conner PM, Friend SH, Fornace AJ Jr, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, Osdol WW van, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE, Paull KD (1997) An information-intensive approach to the molecular pharmacology of cancer. Science 275:343-349
22. Wheeler BM, Loehrer PJ, Williams SD, Einhorn LH (1986) Ifosfamide in refractory male germ cell tumors. J Clin Oncol 4:28-34